SCR-LIP-000331 · Claim · machine-readable JSON →
This systematic review of molecular and cellular lipedema research interprets lymphedema co-occurring in advanced stages as a consequence of associated obesity rather than a primary feature of lipedema, and proposes adding comorbidities like obesity and lymphedema to revised staging; it does not establish that lipedema itself progresses to lymphedema or quantify functional disability.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- very low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 1 question(s)
- Dates
- 2026-05-31 → 2026-05-31
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31
Evidence over time
Evidence (1)
- Lipedema Research—Quo Vadis? — Ernst et al. (2023) ✓ verified — refining · review · 2023 · reading confidence: moderate
“Linfedema como co-ocorrência de estágios avançados interpretada como consequência da obesidade associada — não causa primária de lipedema”
The article addresses the lipedema-lymphedema relationship but explicitly frames lymphedema as a secondary co-occurrence linked to obesity rather than direct progression of lipedema, and focuses on molecular/cellular mechanisms without meas
Context (PECO)
Answers these questions
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-05-31 — created · auto-ingested for SQ-LIP-000017